Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives

touchPANEL DISCUSSION for touchNEUROLOGY Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease The experts Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Eisai Inc. Jointly provided by Partners for Advancing Clinical Education and touchIME in collaboration with the Gerontological Society of America (GSA). For further information, visit:  www.touchNEUROLOGY.com